MedTrace Logo

Dosing Study of Amino Acids in Seriously Ill Patients

NCT01923480 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-03-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the best rate of infusion of amino acids (15% CLINISOL - sulfite-free (Amino Acid) Injection) for nutrition in subjects with with stages II to IVB head and neck cancer.

Conditions

  • Parenteral Nutrition (No Primary Condition Studied)

Interventions

DRUG

15% CLINISOL - Sulfite-free (Amino Acid) Injection

DRUG

15% CLINISOL - Sulfite-free (Amino Acid) Injection

DRUG

15% CLINISOL - Sulfite-free (Amino Acid) Injection

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01923480 on ClinicalTrials.gov